Abstract
A B S T R A C T A data journal in the biomedical field is an innovative task with potential benefits to the scientific society, the pharmaceutical and biotechnology industries, as well as the medical institutions and authorities. It can serve as a source to stimulate, using computational modeling and bioinformatics, the bridging of biomedicine and basic biology researches and connecting pharmaceutical and biotechnology industries with academy. In the era of various high throughput technologies and big data, it could become a powerful driving force to combine expertise to understand the complexity of life and to catalyze new innovative therapeutics and diagnosis. The developments of various high-throughput and/or high-content drugscreening techniques are aiming not only to probe a large number of chemical compounds, but also to obtain deep insights into the molecule/molecule interaction associated with the diversity of chemical space, the structure-activity relationship, as well as the pharmacological mechanism. Moreover, the cellbased drug-screening approaches can shed new light on the dynamics and regulation of proteins and genes associated with various physiological and pathological states.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
